Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. (2021)

First Author: Amirthalingam G
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-27410-5

PubMed Identifier: 34893611

Publication URI: http://europepmc.org/abstract/MED/34893611

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723